Research funders now treat end-of-life dementia care as a priority worth dedicated money and committee time, not an afterthought to drug trials. In 2025 and 2026, US and UK researchers converged on the same finding: families caring for someone dying with dementia are not getting the information, training, or support they need, and new funding and priority-setting efforts are aimed directly at closing that gap. For a family caregiver watching a parent or spouse decline, this shift matters less as abstract policy and more as a signal of what's coming — better guidance on what to expect, more honest conversations with clinicians, and research that finally measures the problems caregivers already know firsthand.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What changed in dementia end-of-life research funding this year
- Why families, not just scientists, set the research agenda
- What families are actually experiencing right now
- What Dementia UK's report recommends changing
- Why this funding pipeline isn't guaranteed to continue
- Frequently Asked Questions
What changed in dementia end-of-life research funding this year
The US National Institutes of Health committed $64 million over five years, announced in August 2025, to launch the ASCENT Consortium. Led by the Icahn School of Medicine at Mount Sinai with Duke University and other partners, the consortium builds research infrastructure for palliative care across serious illnesses, explicitly including Alzheimer's disease and related dementias, according to Mount Sinai's announcement. A companion NIH funding notice, PAR-27-090, invites researchers to apply for R01 grants studying palliative care access, use, and quality for people with serious illness and their care partners.
Investigators who receive this funding join the ASCENT Consortium's research network, and dementia is named explicitly as a focus area, per the NIH grant notice. Separately, a National Academies committee, convened at the request of the National Institute on Aging (NIA) and the National Institute of Neurological Disorders and Stroke (NINDS), released "Preventing and Treating Dementia: Research Priorities to Accelerate Progress" in late 2024 and early 2025. The report sets 11 research priorities intended to build on earlier NIH summit work, according to the National Academies' report summary. Together, these efforts mark the first time dementia-specific palliative care has its own dedicated federal infrastructure rather than being folded into general aging research.
Why families, not just scientists, set the research agenda
In the UK, the Marie Curie and James Lind Alliance partnership refreshed its palliative and end-of-life care research priorities list on October 30, 2025. The single highest-ranked priority, above pain management, above service delivery models, is a direct question: how do people with dementia experience the end of life, and how can care better meet the needs of patients, carers, friends, and families? This ranking came from patients, caregivers, and clinicians working together, not researchers alone, according to Marie Curie's priority-setting project. The same analysis uncovered a stark funding mismatch: only 0.23% of UK health-related non-commercial research funding in 2022 went to palliative care research, even though roughly 90% of people who die need this kind of care, per Marie Curie's findings.
That gap is the explicit justification for pushing dementia end-of-life research to the top of the list — the need is nearly universal, but the research investment has been negligible. This pattern, where lived experience drives what gets studied, is becoming the norm rather than the exception. It means future research is more likely to address the practical, day-to-day problems caregivers report, rather than questions that interest only lab scientists.
What families are actually experiencing right now
Dementia UK's report, "A Better Death: Fixing Palliative and End of Life Care for Dementia," was launched in Westminster in March 2026 and quantifies what many caregivers already sense. Of families surveyed, 46% said they were not told what to expect as their relative with dementia approached death, and 71% of current or former carers said they did not receive enough support, according to Dementia UK's report.
A separate scoping review, published January 28, 2026, in the American Journal of Hospice & Palliative Medicine, screened 731 studies down to 12 relevant ones and found four recurring service gaps for home end-of-life dementia care: a lack of basic hospice information, strained communication with clinicians, and financial and scheduling strain caused by poor guidance on managing symptoms, per the journal's scoping review. These two findings reinforce each other. One shows caregivers don't know what's coming; the other shows that even when they're navigating active symptom management at home, the practical support — clear instructions, responsive communication, financial planning — is often missing.
What Dementia UK's report recommends changing
The Dementia UK report doesn't stop at describing the problem. It recommends earlier advance care planning conversations, better training for staff on end-of-life dementia care, and stronger caregiver support through education, respite care, and emotional support.
It also calls for specialist input, such as Admiral Nurses (dementia specialist nurses), and urges governments to formally recognize dementia as a life-limiting condition, according to Dementia UK's recommendations. Formal recognition of dementia as life-limiting matters practically. It affects whether palliative and hospice services are offered proactively, rather than only after a crisis, and whether health systems plan and fund for a slow decline rather than treating dementia as a chronic condition without the same end-of-life pathway as cancer.
- Ask the care team directly whether advance care planning has started, and request it early if not.
- Ask explicitly what physical and cognitive changes to expect in the final months, since this information is often not volunteered.
- Ask about access to a dementia specialist nurse or equivalent, where available, rather than general palliative staff alone.
- Ask about respite care and emotional support options before reaching a crisis point.
Why this funding pipeline isn't guaranteed to continue
The research infrastructure described above depends on continued federal funding, and that funding is not automatic year to year. The American Academy of Hospice and Palliative Medicine (AAHPM) submitted testimony on April 16, 2026, for the FY2027 Labor-HHS appropriations process, requesting $12.5 million specifically for the NIA to keep coordinating the multi-disease Consortium for Palliative Care Research Across the Lifespan, according to AAHPM's testimony.
That request underscores that the consortium coordinating much of this dementia-relevant palliative care research operates on year-to-year appropriations, not a permanent budget line. For family caregivers, this means the pipeline producing better guidance, training standards, and support models is active now but depends on continued congressional funding decisions rather than being a settled, permanent program.
Frequently Asked Questions
Does any of this new research funding directly pay for caregiver support services today?
No. The ASCENT Consortium and the NIA-coordinated consortium fund research infrastructure and studies, not direct caregiver services; AAHPM's 2026 testimony notes this funding is appropriated year to year.
Is dementia formally classified as a life-limiting condition in the US or UK?
Dementia UK's March 2026 report calls on governments to formally recognize dementia as life-limiting, indicating this recognition is a recommendation, not yet an established policy.
You Might Also Like
- Dementia Subtype Data Gaps Identified by NIA in 2026: Who Was Studied and Who Was Not for Family Caregivers
- Privacy and Data Access Gaps in 2026 Dementia Research: Who Was Studied and Who Was Not for Family Caregivers
- UAS-CLEAR Dementia Care Research Data Priorities in 2026: How Adults With Memory Concerns Can Avoid Overreading the Headline
